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Abstract
Genome-wide scans for positively selected genes (PSGs) in mammals have provided insight into the dynamics of genome
evolution, the genetic basis of differences between species, and the functions of individual genes. However, previous scans
have been limited in power and accuracy owing to small numbers of available genomes. Here we present the most
comprehensive examination of mammalian PSGs to date, using the six high-coverage genome assemblies now available for
eutherian mammals. The increased phylogenetic depth of this dataset results in substantially improved statistical power,
and permits several new lineage- and clade-specific tests to be applied. Of ,16,500 human genes with high-confidence
orthologs in at least two other species, 400 genes showed significant evidence of positive selection (FDR,0.05), according
to a standard likelihood ratio test. An additional 144 genes showed evidence of positive selection on particular lineages or
clades. As in previous studies, the identified PSGs were enriched for roles in defense/immunity, chemosensory perception,
and reproduction, but enrichments were also evident for more specific functions, such as complement-mediated immunity
and taste perception. Several pathways were strongly enriched for PSGs, suggesting possible co-evolution of interacting
genes. A novel Bayesian analysis of the possible ‘‘selection histories’’ of each gene indicated that most PSGs have switched
multiple times between positive selection and nonselection, suggesting that positive selection is often episodic. A detailed
analysis of Affymetrix exon array data indicated that PSGs are expressed at significantly lower levels, and in a more tissue-
specific manner, than non-PSGs. Genes that are specifically expressed in the spleen, testes, liver, and breast are significantly
enriched for PSGs, but no evidence was found for an enrichment for PSGs among brain-specific genes. This study provides
additional evidence for widespread positive selection in mammalian evolution and new genome-wide insights into the
functional implications of positive selection.
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Introduction
Positive darwinian selection is an important source of evolution-
ary innovation and a major force behind the divergence of species.
The Neutralist-Selectionist debate of the past 30 years has gradually
given way to a general consensus that both neutral drift and positive
selection play major roles in evolutionary change. Interest has
therefore shifted to questions of which genes positive selection has
affected, how strong was the effect, when did it occur, and what
were its functional consequences. Heightening interest in these
questions is a growing appreciation that methods for detecting
positive selection can also be valuable tools for gaining insight into
gene function [1]. Consequently, a wide variety of methods for
detecting positively selected genes (PSGs) have been introduced,
including comparative or phylogenetic methods, which make use of
patterns of substitutions between species, and population genetic
methods, which primarily rely on patterns of intraspecies polymor-
phism [2,3]. Using these techniques, strong evidence of positive
selection has been found for various genes in various organisms,
including many genes involved in sensory perception, immunity,
host-pathogen interactions, and reproduction (reviewed in [1,3]).
Phylogenetic and population genetic methods for detecting
positive selection serve as complementary tools for functional and
evolutionary analysis. These methods operate at different time
scales, with phylogenetic methods being best suited for detecting
selection that operates over relatively long periods in evolutionary
history, and population genetic methods being best suited for
detecting more recent selection. Population genetic methods can
potentially detect selection operating at individual sites, through the
effects of linkage with flanking alleles, while phylogenetic methods
generally require multiple sites to have been affected in a sequence
of interest. At the same time, decay of linkage disequilibrium at
longer evolutionary time scales can allow phylogenetic methods to
more accurately pinpoint the specific locations of functionally
important substitutions. In some cases, phylogenetic methods also
allow such substitutions to be mapped to particular branches of a
phylogenetic tree, thereby providing useful insights about the
evolutionary histories of the sequences in question.
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With the availability of multiple complete genome sequences, it
has become possible to apply phylogenetic methods for the
detection of positive selection at a genome-wide scale. Within
mammals, several genome-wide scans for positive selection on
protein-coding genes have been conducted, using both phyloge-
netic [4,5,6,7,8,9] and population genetic [10,11,12,13,14,15]
methods (reviewed in [16]). These analyses have identified many
new genes showing strong evidence of positive selection and have
revealed striking differences in the prevalence of positive selection
on different lineages and among different classes of genes. For
example, it has been reported that PSGs are enriched for roles in
sensory perception, immunity and defense, tumor suppression,
apoptosis, and spermatogenesis [4,5]; that PSGs are associated
with known Mendelian disorders [4]; that PSGs often coincide
with segmental duplications [8]; and that more genes have
undergone positive selection in chimpanzee evolution than in
human evolution [9]. Genome-wide scans for PSGs have also
helped to stimulate interest in detecting positive selection on
noncoding sequences and on gene expression [17,18,19,20].
Nevertheless, much remains to be learned about positive
selection in mammalian genomes, even within protein-coding
regions. The most comprehensive scans for PSGs so far [4,5,7,8,9]
have been based on at most three genome sequences—typically
the highly similar human, chimpanzee, and/or rhesus macaque
genomes (.97% average identity in orthologous coding regions
[8]). As a result, the power for detection of PSGs has been
relatively weak [5,8]. In addition, in several of these studies, at
least one genome was of draft quality, which reduced the number
of genes that could be examined and required additional care in
avoiding false positive predictions.
Here we present a phylogenetic analysis of positive selection in
the six eutherian mammalian genomes for which high-coverage,
high-quality sequence assemblies are now available: the human
[21], chimpanzee [6], macaque [8], mouse [22], rat [23], and dog
[24] genomes. The phylogenetic depth of this data set helps
considerably in addressing the problem of weak power. Indeed,
these genomes have a near-optimal degree of divergence for PSG
detection, being distant enough to produce a strong phylogenetic
signal, yet close enough that gene structures are well conserved,
alignment is fairly straightforward, and synonymous substitutions
are not saturated (e.g., [25]). In addition, our data set for the first
time allows positive selection of mammalian genes to be examined
genome-wide on a nontrivial phylogeny, so that insight can be
gained into the particular ‘‘selection histories’’ of individual
genes—that is, the branches of the phylogeny on which they
experienced positive selection. In our analysis, we employ models
of codon substitution that account for variation of selective
pressure over branches on the tree and across sites in a sequence,
which can capture signatures of molecular adaptation that affect
small numbers of sites [26,27]. Using a series of likelihood ratio
tests (LRTs) based on these models, we identify more than four
hundred genes that show strong signatures of positive selection
during mammalian evolution. Our detailed analysis of the
functional roles, selection histories, and expression patterns of
these genes follows.
Results
Orthologous Genes
Using the latest human, chimpanzee, macaque, mouse, rat, and
dog genome assemblies, we identified 17,489 human genes with
high-confidence orthologs in at least two of the remaining five
species. These ortholog sets (human genes and non-human orthologs)
were identified by an automatic pipeline that made use of syntenic
whole-genome alignments, sequence quality scores, and other data
(see Methods). Briefly, the pipeline began with 21,115 human
genes drawn from the RefSeq [28], UCSC Known Genes [29],
and VEGA [30] gene sets. These genes were mapped to the other
genomes via syntenic pairwise alignments, then passed through a
series of rigorous filters to ensure correct mapping, high sequence
quality, and only minimal changes between species in gene
structure. This approach exploits the fact that gene structures are
generally well-conserved between mammalian species [22] and
avoids any dependency on the non-human gene annotations,
which—with the exception of mouse—are significantly less
accurate and complete than those for human. Because low-quality
sequence can produce a spurious signal for positive selection (e.g.,
[8]), all bases with low quality scores (Phred quality ,20) were
masked out for subsequent analyses. Masking (or truncation at the
59 or 39 end) was also used to exclude regions of genes in which
minor differences in gene structure were apparent. Genes that
showed signs of substantial disruptions to their exon-intron
structures or open reading frames in one or more species (perhaps
indicating pseudogenization) were masked out completely in those
species. All masked bases were treated as missing data in the
subsequent analysis of positive selection. This masking approach
allowed the number of genes to be maximized while ensuring that
the analyzed alignments were of high quality (Table 1).
For this study, we chose to avoid recently duplicated gene
families and to focus on 1:1 orthologs. This simplified the analysis,
allowed for parameter sharing across genes (see Methods), and
eliminated an important source of error by avoiding the need for a
separate tree reconstruction for each gene family. (All ortholog sets
were assumed to obey the species tree shown in Figure 1; because
only an unrooted tree is needed, the topology is well accepted.) It
was therefore necessary to discard any genes that showed evidence
of recent duplication. This was accomplished in a pairwise fashion,
by examining each human gene and orthologous non-human
gene, and determining—based on BLAST matches to other genes
and gene predictions in the same genome—whether either gene
had a paralog that was more similar to it than the two orthologs
Author Summary
Populations evolve as mutations arise in individual
organisms and, through hereditary transmission, gradually
become ‘‘fixed’’ (shared by all individuals) in the popula-
tion. Many mutations have essentially no effect on
organismal fitness and can become fixed only by the
stochastic process of neutral drift. However, some
mutations produce a selective advantage that boosts their
chances of reaching fixation. Genes in which new
mutations tend to be beneficial, rather than neutral or
deleterious, tend to evolve rapidly and are said to be under
positive selection. Genes involved in immunity and
defense are a well-known example; rapid evolution in
these genes presumably occurs because new mutations
help organisms to prevail in evolutionary ‘‘arms races’’ with
pathogens. Many mammalian genes show evidence of
positive selection, but open questions remain about the
overall impact of positive selection in mammals. For
example, which key differences between species can be
attributed to positive selection? How have patterns of
selection changed across the mammalian phylogeny?
What are the effects of population size and gene
expression patterns on positive selection? Here we
attempt to shed light on these and other questions in a
comprehensive study of ,16,500 genes in six mammalian
genomes.
Positive Selection in Mammals
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were to each other (see Methods). Requiring that each human
gene had a high-confidence 1:1 ortholog in at least two other
species reduced the total number of ortholog sets to 16,529. These
sets contain a human gene and either five (42% of cases), four
(28%), three (15%) or two (15%) non-human orthologs.
Likelihood Ratio Tests for Positively Selected Genes
We performed a series of nine different LRTs to identify genes
under positive selection on particular branches or clades of interest
in the six-species phylogeny. In particular, we tested for selection
on any branch of the tree (Figure 1A); on the branch leading to,
and on any branch within, the primate clade (Figure 1B,C); on the
branch leading to, and on any branch within, the rodent clade
(Figure 1D,E); and on each of the four individual branches within
the primate clade (Figure 1F–I). These LRTs were all based on
widely used site or branch-site models of codon evolution
[31,26,27] (see Methods). The test for all branches was applied
to all 16,529 ortholog sets. For the branch- and clade-specific tests,
ortholog sets were discarded if they did not contain adequate in-
group or out-group data for the test in question, which somewhat
reduced the number of tests (Text S1, Table S1).
The PSGs identified by each test ranged in number from only
seven (the hominid branch) to 400 (the test for all branches;
FDR,0.05 in all cases). As in previous studies, the numbers of
genes identified by the tests for individual primate branches were
small, primarily due to weak power caused by low levels of inter-
species divergence. The inclusion of additional non-primate
mammals does not appear to have improved the power of these
tests substantially, but it does allow a distinction to be made
between selection on the branches to the hominids and to
macaque. The tests for selection on the branch to the primates and
in the primate clade also yielded fairly small numbers of PSGs, but
the tests for selection in, or on the branch to, the rodents identified
somewhat (nearly three-fold) larger numbers. In general, even with
Table 1. Numbers of ortholog sets.
containing containing containing containing containing
all chimpanzee macaque mouse rat dog
Human + $ 2 orthologs 17,489 15,315 14,973 14,266 12,823 13,696
Incomplete transcripts 6,113 5,317 5,219 5,037 4,562 4,938
Recent duplications 2,273* 745 816 1,476 1,319 1,089
After duplication removal 16,529 14,570 14,157 12,790 11,504 12,607
*Recently duplicated genes are removed, but orthologs sets are retained if they still contain a human gene and $2 orthologs.
doi:10.1371/journal.pgen.1000144.t001
Figure 1. The LRTs used to detect positive selection in the six mammalian genomes. (A–I) Panel A shows the test for selection on any
branch of the phylogeny, and panels B–I show the lineage- and clade-specific tests, with branches under positive selection highlighted. The numbers
below each subfigure represent the number of positively selected genes identified by each LRT (FDR,0.05) and the total number of ortholog sets
tested. In (A), branch lengths are drawn proportional to their estimates in substitutions per site, and each branch is labeled with the corresponding
estimate of v. All tests are based on an unrooted phylogeny; the trees are rooted for display purposes only. Nominal P-value thresholds for FDR,0.05
were: (A) 1.161023, (B) 9.161025, (C) 7.761025, (D) 2.961024, (E) 2.861024, (F) 2.561025, (G) 5.461025, (H) 1.861025, (I) 5.961025.
doi:10.1371/journal.pgen.1000144.g001
Positive Selection in Mammals
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the larger data set, our power to detect selection on individual
lineages and clades is still fairly weak, and differences in numbers
of identified PSGs almost certainly reflect differences in power
more than differences in the prevalence of selection. Nevertheless,
these LRTs together produced a fairly large set of high-confidence
PSGs, permitting a more detailed and thorough functional analysis
than has previously been possible in mammals (see below).
Functional Analysis of Positively Selected Genes
The identified PSGs are significantly enriched for a large
number of functional categories, according to the Gene Ontology
(GO) [32] and Protein Analysis Through Evolutionary Relation-
ships (PANTHER) databases (Tables 2, S2, and S3). If these over-
represented categories are clustered by the PSGs that are assigned
to them, major groups corresponding to sensory perception,
immunity, and defense emerge (Figure 2), in agreement with
previous genome-wide scans [4,5]. However, the increased power
of our analysis allows biological processes and functions associated
with positive selection to be identified at much finer resolution
than in previous analyses, as discussed below. The increased power
also seems to diminish the dependency of functional enrichments
on the database or statistical methodology selected for the analysis.
In particular, better agreement was observed between functional
categories over-represented among the identified PSGs, as
determined by Fisher’s exact test (FET), and categories whose
genes displayed significant shift toward smaller LRT P-values
(whether or not they met the significance threshold for PSGs), as
determined by the Mann-Whitney U (MWU) test (see Methods).
Better agreement was also observed between analyses based on the
GO and PANTHER databases (see Tables S2 and S3). The
observed enrichments do not appear to be an artifact of differences
between categories in gene length or alignment depth per gene
(Text S1). In the discussion below, we focus on GO categories and
nominal P -values based on the MWU test, as applied to P-values
from the LRT for selection on any branch of the tree (except when
otherwise indicated); full results are shown in Table 2 and Text S1.
Immunity and Defense
The PSGs are enriched for a wide variety of functions related to
immunity and defense. Several over-represented categories
describe activation in response to external or environmental
stresses, such as from bacteria (P=4.261028), viruses
(P=3.061028), wounding (P=3.261028), and acute inflamma-
tion (P=4.7610211). In some cases, different categories reflect the
same or very similar sets of genes (e.g., ‘‘response to wounding’’
and ‘‘acute inflammatory response,’’ or ‘‘response to virus’’ and
‘‘response to bacterium’’), while in others they reflect quite distinct
gene sets (‘‘response to wounding’’ and ‘‘response to virus’’)
(Figure 2). Genes involved in both innate (P=1.961029) and
adaptive (P=1.561025) immunity are over-represented, with
many PSGs contributing to both classes. The conventional division
of adaptive immunity into humoral (P=1.661027) and cellular
(P=3.561027) responses is reflected in the enriched GO
categories. Various mechanisms of immune response are repre-
sented, including previously identified categories for natural killer
cell (P=1.661028), B-cell (P=4.861027), and T-cell
(P=1.261028) mediated immunity [5,8], and new categories
such as cytokine/chemokine-mediated (7.661028) and comple-
ment-mediated immunity (P=6.061026; see Table S3).
Some of the enriched categories point to particular pathways
with large numbers of PSGs. A striking example is the complement
immunity system, a biochemical cascade responsible for the
elimination of pathogens. This system consists of several small
proteins found in the blood that cooperate to kill target cells by
disrupting their plasma membranes. Of 28 genes associated with
this pathway in KEGG [33], nine are identified as PSGs
(FDR,0.05), and five others have nominal P,0.05 (Figure S1).
Most of these PSGs are inhibitors (DAF, CFH, CFI) and receptors
(C5AR1, CR2), but some are part of the membrane attack complex
(C7, C9, C8A), which punctures cell membranes to initiate cell lysis.
Many of these PSGs are known to interact with one another,
suggesting possible co-evolution. Two of three biochemical
pathways known to activate the complement system are also
enriched for PSGs (the classical complement pathway
[P=6.161027] and the alternative complement pathway
[P=1.561026]), as is the coagulation cascade that interacts with
the complement system (‘‘blood clotting,’’ MWU P=2.261027;
Table S3). Other pathways that contain multiple interacting PSGs
include those for apoptosis, taste transduction, antigen processing
and presentation, and cytokine- and chemokine-mediated signal-
ing (e.g., Figures. S4, S5).
Several gene families of the immunoglobulin superfamily
(‘‘immunoglobulin mediated immune response,’’ P=1.161027)
show particularly strong enrichments for PSGs. For example, five
of the six SIGLEC genes included in our analysis are under positive
selection (see [34]). A detailed examination of one immunoglob-
ulin gene for which structural information was available—a cell-
surface receptor for hepatitis A and other viruses called HAVCR1
(LRT P=6.961029)—revealed several sites under positive
selection in its N-terminal V-like immunoglobulin (IgV) domain.
Three of these sites correspond to regions of the protein believed
to play critical roles in binding to viruses or in regulating the
immune function of the gene (Figure 3). In addition to its role in
viral defense, HAVCR1 is a key player in the hygiene hypothesis
explaining the increase in allergies and asthma [35]. It also
interacts with IgA (CD79A; P=5.461029), whose deficiency is
associated with increased susceptibility to autoimmune and allergic
diseases [36].
The hierarchical clustering of GO categories (Figure 2) reveals
an unexpected similarity between the sets of PSGs involved in
fertilization and cytolysis, and some similarity of both sets with
immune-related PSGs. This association of immunity, fertilization,
and cytolysis is driven by a group of genes that participate in
sperm-egg interaction, but also have immune-related functions
and destroy pathogens by cytolysis. Interestingly, PSGs with roles
in both reproduction and immunity are often also related to
cancer, and it has been hypothesized that most cancer genes under
positive selection have been subject to antagonistic co-evolution,
with lineage-specific variations in dynamics and strength [5,37].
Several PSGs identified here are associated with both FAS/p53
apoptosis and cancer (Da Fonseca et al., in prep.), such as the
protein p53, which also regulates maternal reproduction [38]; the
cell adhesion gene ADAM2 (P=2.961026), which is integral to
fertilization [39]; and the related genes ADAM15 (P=5.461024)
and ADAM29 (P=3.461024), which are strong candidates for
cancer evolution driven by sexual conflict. In addition, the testes
development-related gene CCDC54 (P=3.361024) is currently a
target of cancer immunotherapy research [40].
Sensory Perception
A smaller and somewhat less diverse group of enriched
categories is associated with sensory perception. Among the most
inclusive categories of this type are ‘‘sensory perception of
chemical stimulus’’ (24 PSGs; P=4.3610239) and ‘‘G-protein
coupled receptor protein signaling pathway’’ (39 PSGs;
P=1.461027). Previously, enrichments for such categories have
been attributed primarily to olfactory receptors [4,5]. Indeed, 15
PSGs are labeled as having ‘‘olfactory receptor activity’’
Positive Selection in Mammals
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Table 2. Selected GO categories over-represented among genes predicted to be under positive selection.
Gene number Fold P-value P-value
Category Description All PSGs E[PSGs] Enrich. MWU FET
Biological process
GO:0007606 sensory perception of chemical stimulus 255 24 6.2 3.9 4.3610239 1.5610208
GO:0007608 sensory perception of smell 229 15 5.5 2.7 6.1610231 4.8610204
GO:0002526 acute inflammatory response 55 11 1.3 8.3 4.7610211 6.7610208
GO:0050909 sensory perception of taste 25 8 0.6 13.2 1.4610210 8.3610208
GO:0009611 response to wounding 321 23 7.8 3.0 3.2610210 6.9610206
GO:0002541 activation of plasma proteins during acute inflammatory response 28 7 0.7 10.3 1.3610209 3.5610206
GO:0006956 complement activation 28 7 0.7 10.3 1.3610209 3.5610206
GO:0045087 innate immune response 70 8 1.7 4.7 1.9610209 3.7610204
GO:0009615 response to virus 69 7 1.7 4.2 3.0610208 2.4610203
GO:0009617 response to bacterium 67 6 1.6 3.7 4.2610208 7.9610203
GO:0002682 regulation of immune system process 60 11 1.5 7.6 8.5610208 1.0610206
GO:0016064 immunoglobulin mediated immune response 36 8 0.9 9.2 1.1610207 1.5610205
GO:0007186 G-protein coupled receptor protein signaling pathway 792 39 19.2 2.0 1.4610207 2.5610205
GO:0006959 humoral immune response 56 9 1.4 6.6 1.6610207 7.2610206
GO:0050778 positive regulation of immune response 49 9 1.2 7.6 1.7610207 8.4610206
GO:0002455 humoral immune response mediated by circulating immunoglobulin 24 6 0.6 10.3 3.0610207 1.8610205
GO:0019724 B cell mediated immunity 37 8 0.9 8.9 3.2610207 1.8610205
GO:0006968 cellular defense response 55 5 1.3 3.8 3.5610207 1.1610202
GO:0019882 antigen processing and presentation 27 4 0.7 6.1 5.7610207 5.0610203
GO:0006958 complement activation, classical pathway 23 6 0.6 10.8 6.1610207 1.4610205
GO:0050877 neurological process 811 34 19.6 1.7 7.5610207 1.5610203
GO:0006957 complement activation, alternative pathway 11 2 0.3 7.5 1.5610206 2.8610202
GO:0019835 cytolysis 15 3 0.4 8.3 2.2610206 5.2610203
GO:0002449 lymphocyte mediated immunity 53 10 1.3 7.8 5.7610206 2.5610206
GO:0002460 adaptive immune response based on somatic recombination of immune
receptors built from immunoglobulin superfamily domains
57 13 1.4 9.4 8.0610206 1.1610208
GO:0002250 adaptive immune response 58 13 1.4 9.3 1.5610205 1.1610208
GO:0007338 single fertilization 39 4 0.9 4.2 1.7610205 1.4610202
Molecular function
GO:0004984 olfactory receptor activity 229 15 5.5 2.7 6.9610236 6.8610204
GO:0004930 G-protein coupled receptor activity 625 37 15.1 2.4 2.5610214 5.1610207
GO:0004888 (*) transmembrane receptor activity 972 55 23.5 2.3 4.0610212 3.3610209
GO:0008527 taste receptor activity 14 5 0.3 14.8 1.3610208 1.4610205
GO:0008009 chemokine activity 34 5 0.8 6.1 3.7610207 1.3610203
GO:0004866 endopeptidase inhibitor activity 110 6 2.7 2.3 4.1610207 5.1610202
GO:0019965 interleukin binding 33 1 0.8 1.3 2.2610206 5.5610201
GO:0005125 cytokine activity 184 13 4.5 2.9 7.8610206 5.8610204
GO:0008173 RNA methyltransferase activity 19 1 0.5 2.2 8.4610206 3.7610201
GO:0004907 interleukin receptor activity 28 1 0.7 1.5 1.1610205 5.0610201
GO:0017171 serine hydrolase activity 150 9 3.6 2.5 2.1610205 1.1610202
Cellular component
GO:0005615 extracellular space 354 19 8.6 2.2 6.8610208 4.1610203
GO:0042611 MHC protein complex 14 4 0.3 11.8 2.8610207 2.8610204
GO:0016021 (*) integral to membrane 3799 168 91.9 1.8 8.9610206 1.0610216
Shown are numbers of PSGs and of all genes (out of 16,529 considered) assigned to each category or a descendant category, and one-sided (nominal) P-values from the
Mann-Whitney U (MWU) and Fisher’s exact (FET) tests (see Methods). Only the 400 PSGs from the test for selection on any branch of the phylogeny are considered here.
Note that the MWU P -values do not consider whether or not each gene is predicted to be a PSG, but instead indicate the degree to which the LRT P -values for the
genes of each category are shifted toward small values. Consequently, classes of genes experiencing relaxation of constraint but not positive selection may obtain small
MWU P -values. In contrast, the FET P -values indicate over-representation of the identified PSGs within each category (or, equivalently, over-representation of each
category among the PSGs). Bold indicates significance after a conservative correction for multiple testing (FWER,0.05, Holm correction). The two categories with
asterisks are enriched for long genes (see Text S1). Only selected categories FWER-significant P -values under the MWU test are shown; see Table S2 for a complete list.
doi:10.1371/journal.pgen.1000144.t002
Positive Selection in Mammals
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(P=6.9610236). However, eight PSGs are involved in ‘‘sensory
perception of taste,’’ including five taste receptors (P=1.4610210).
Interestingly, several of these are bitter taste receptors. The sense
of bitter taste is critical in allowing organisms to avoid toxic and
harmful substances, and extensive gene expansion of bitter taste
receptors is known to have occurred during mammalian evolution
[41], possibly driven by (or helping to drive) positive selection.
Bitter taste receptors under positive selection include TAS2R1,
TAS2R5, and a recently expanded cluster of genes at chr12p13
(TAS2R13, TAS2R14, TAS2R42, and TAS2R49). Another PSG,
TAS1R2, is a receptor of sweet and umami taste, and the PSG
RTP3 is a transmembrane protein that is involved in the transport
of taste receptors and apparently influences their expression.
The PSGs in the ‘‘neurological processes’’ category
(P=7.561027) are dominated by olfactory and taste receptors,
but they also include other types of genes. For example, TMC2
(P=1.161024) is expressed in the inner ear and is important for
balance and hearing [42]. The acid-sensing ion channel gene
ACCN4 (P=1.061026) has been implicated in synaptic transmis-
sion, pain perception, and mechanoperception [43]. SLC6A5
(P=3.061024) is associated with hyperekplexia, a neurological
disorder characterized by an excessive startle response [44]. The
neuromedin receptor NMUR (P=6.161024) is involved in the
mammalian circadian oscillator system [45,46]. Finally, the
neurotensin receptor NTSR1 (P=8.161024) mediates hypoten-
sion, hyperglycemia, hypothermia, antinociception, and regulation
of intestinal motility and secretion [47].
Similarly, the PSGs associated with diet include but are not
limited to taste and olfactory receptors. For example, MGAM
(P=2.461028) is essential for the small intestinal digestion of
starch, giving it a critical role in human metabolism, as starches of
plant origin make up two-thirds of most human diets [48] (see also
[49]). MAN2B1 (P=161026) is involved in the cleavage of the
alpha form of mannose, a sugar monomer. Defects in this gene
cause lysosomal alpha-mannosidosis, a lysosomal storage disease
characterized by the accumulation of unbranched oligosaccharide
chains [50]. TCN1 (P=2.9610231) is a major constituent of
secondary granules in neutrophils and facilitates the transport of
vitamin B12 into cells, which is important for the normal
functioning of the brain and nervous system, and for the formation
of blood [51]. In addition, several PSGs participate in ‘‘steroid
hormone metabolism’’ (P=8.361024) including genes that
metabolize xenobiotics and drugs (e.g., SULT1C3, UGT2B7, and
CYP2C8). Positive selection in these and other genes is likely to
Figure 2. Hierarchical clustering of 27 over-represented GO categories identified by the Mann-Whitney U test (‘‘biological process’’
group only), based on the genes assigned to each category. This dendrogram is derived from a dissimilarity matrix defined such that any two
GO categories, X and Y, have dissimilarity 0 when all genes assigned to X are also assigned to Y (or vice-versa), and dissimilarity 1 when the sets of
genes assigned to X and Y do not overlap. Specifically, X and Y have dissimilarity dXY~1{ N Xð Þ\N Yð Þj j=min N Xð Þj j, N Yð Þj jf g, where N Cð Þ
denotes the (nonempty) set of genes assigned to GO category C. Thus, GO categories associated with similar sets of genes group together in the
dendrogram, even if these categories are not closely related in the GO hierarchy (such as ‘‘cytolysis’’ and ‘‘single fertilization’’). Full names of
abbreviated categories (*) are ‘‘humoral immune response mediated by circulating immunoglobulin,’’ ‘‘activation of plasma proteins during acute
inflammatory response,’’ and ‘‘adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin
superfamily domains.’’ (Dendrogram produced by the hclust function in R with method= ‘‘average’’.)
doi:10.1371/journal.pgen.1000144.g002
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have been influenced by changes in food preferences during
mammalian evolution.
Differences between Primates and Rodents
Few functional enrichments were evident for the PSGs
identified by the branch- and clade-specific LRTs, primarily
because these sets were quite small in size. However, the more
powerful LRTs, such as those for the primate and rodent clades
(Figure 1C,E), did produce significantly lower P-values for genes of
certain functional categories than for others. Interestingly, these
categories were dramatically different for the primate- and rodent-
clade LRTs, with nearly all of the primate categories relating to
sensory perception, and nearly all of the rodent categories relating
to immunity and defense (Table 4). Indeed, the PSGs identified by
the primate-clade test include several taste and olfactory receptors,
as well as receptors for the sensation of pain (e.g., MRGPRE,
NPFF2) and color vision (e.g., OPN1SW), and receptors involved in
immunity (e.g., CCR1). The PSGs identified by the rodent-clade
test include few such genes, but they include many genes involved
in responses to wounding, inflammation, and stress, as well as
genes involved in complement activation and innate immunity.
Thus, we find little evidence that genes directly involved in brain
development and function have (as a group) been driven by
positive selection in primates, but many genes that provide sensory
Figure 3. Structural analysis of the HAVCR1 gene. At top is a graph showing the domain structure of the gene and corresponding Bayes
Empirical Bayes [83] posterior probabilities (PP) of positive selection, based on our six-species alignments, with sites predicted to be under positive
selection (PP.0.95) in red. At bottom right is a structural diagram (based on the structure of the IgV domain of the mouse gene) showing the
interaction between two receptors that have been implicated in the regulation of HAVCR1’s immune function. It is thought that clustering of
receptors within the same cell surface might facilitate phosphorylation of the cytoplasmic tail, and that interaction between receptors from different
cells might be a mechanism for B–T cell adhesion [91]. Predicted residue 39 falls within the region of these receptors, very near residue 37, which
directly interacts with the opposite receptor (according to the available mouse structure). In addition, predicted residues 54 and 56 are adjacent to
the virus-binding surface (shown in pink), as defined by a polymorphism in macaque [91]. Interestingly, the residue that falls between them (55)
appears to be critical for virus-binding at the homologous loop in the CEA coronavirus receptor [91]. Residue 75 in the IgV domain also shows
evidence of positive selection (PP.0.90, shown in orange) but its function is unknown.
doi:10.1371/journal.pgen.1000144.g003
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information to the brain do appear to have experienced positive
selection. These changes in sensory perception could conceivably
have been brought on by, or could have contributed to, increased
brain size and complexity in primates.
Bayesian Inference of Selection Histories
To gain further insight into the patterns of positive selection that
have shaped present-day mammalian genes, we devised a model
that allows for probabilistic inferences about the selection histories
of individual genes. A selection history is defined as an assignment
to each branch of the phylogeny of one of two evolutionary modes:
positive selection (each site evolves with v0,1, v0 = 1, or v2.1)
or absence of positive selection (each site evolves with v0,1 or
v0 = 1). The model allows a posterior distribution over selection
histories to be inferred for each gene, and it allows for estimates of
the number of genes under positive selection on individual
branches and clades that consider uncertainty about selection
histories. Unlike the branch- and clade-specific LRTs—which are
simple one-sided hypothesis tests and are necessarily conservative
about rejection of the null hypothesis—this model considers all
candidate histories symmetrically, and allows for ‘‘soft’’ (probabi-
listic), rather than absolute, choices of history at each gene.
Briefly, the model is defined in terms of a simple switching
process along the branches of the phylogeny. It has separate
parameters for the rates of gain and loss of positive selection at
several switch points on the tree, with two switch points per
internal branch and one per external branch (see Figure 4A and
Methods). The joint posterior distribution of these parameters and
of all selection histories is inferred from the data by a Gibbs
sampling algorithm (see Methods and Text S1). The inference
procedure is computationally intensive, so it was applied only to
the 544 genes identified by one or more LRTs as showing
significant evidence of positive selection. Because in these cases the
null model of no positive selection had already been rejected by a
conservative test, the history without selection on any branch was
excluded, leaving 2921= 511 possible histories for the nine-
branch (unrooted) phylogeny. To reduce computational cost, the
inference of selection histories was conditioned on the maximum
likelihood estimates of the parameters of the codon models (see
Methods).
The inferred rates of gain and loss are quite variable (Figure 4A
and Figure S2), with posterior means ranging from about 0.01 to
0.53. These rates are sharply reduced for the external branches of
the tree, probably in large part because of diminished power to
detect changes in selective mode on these branches. The number
of genes inferred to be under selection also varies by branch, but
not as dramatically, with expected values ranging between 207.9
and 393.9 and many 95% credible intervals overlapping
(Figure 4B). Despite differences at individual branches, gains and
losses appear to be roughly in equilibrium overall, with 61% of
genes estimated to have been under selection at the root, and
between 38% and 62% (averaging 50%) under selection at the
leaves. The slight tendency to lose selection over time could reflect
an ascertainment bias for genes that experienced selection early in
mammalian evolution, which will tend to display signatures of
selection on multiple long branches of the tree and therefore will
be more easily detectable by the LRTs. The branches with the
most genes under selection (such as those leading to the rodent and
primate ancestors, and to dog and macaque) are generally long
(see Figure 1A), suggesting power may influence these estimates.
Nevertheless, the unusually high rate of gain on the branch to the
rodents, and the comparatively low rate of loss on that branch
(both having fairly low posterior variance; Figure S2), suggest not
just differences in power but a real tendency for a net gain of
selection on this branch, perhaps due to larger population sizes in
the rodents. Whether because of power or a genuine increase in
selection, the rodent branch appears to play a major role in the
identification of PSGs. An expected 72% of the 544 candidate
PSGs are under selection on this branch.
The posterior distributions over histories suggest that few genes
have experienced positive selection specific to individual branches
or clades (Figure 4B). Instead, most genes appear to have switched
Figure 4. Patterns of positive selection on the mammalian phylogeny. (A) Probabilities that each gene gains (green) or loses (red) positive
selection on each branch, under the Bayesian switching model. Switching events are allowed to occur early (near ancestor) or late (near descendant)
on internal branches, and early on external branches. The prior probability of selection at the root of the tree is shown in parentheses. (The primate-
rodent ancestor is treated as the root for this analysis; see Text S1.) The values shown are posterior means. The full posterior distributions are
summarized in Figure S2. (B) Expected numbers of genes under positive selection on each branch (blue) and under positive selection only on each
branch (red), out of the 544 PSGs examined, with 95% credible intervals in parentheses. Branch thicknesses are proportional to numbers in blue.
Similar estimates are also shown for genes under positive selection on all branches of the primate and rodent clades (blue), on only the branches of
these clades (red), and on all branches of the tree (blue). All estimates are based on 10,000 iterations of the Gibbs sampler, excluding a 100 iteration
burn-in period. On each iteration, all switching parameters and the selection histories for all genes were sampled (see Text S1).
doi:10.1371/journal.pgen.1000144.g004
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between evolutionary modes multiple times. The estimated
number of mode switches per gene (averaging across genes but
considering the joint posterior distribution for all selection
histories) is 1.6 (95% CI: 1.5–1.7), with 0.6 gains (0.5–0.7) and
1.0 losses (0.9–1.1). An expected 91% of PSGs have experienced at
least one mode switch, and an expected 53% have experienced
two or more switches. 54% of PSGs have 95% CIs excluding zero
switches (i.e., with high confidence, these genes have switched
modes at least once), and 10% have 95% CIs also excluding one
switch (with high confidence, they have switched modes at least
twice). Thus, this analysis suggests that positive selection tends to
be gained and lost relatively frequently in mammalian genes.
Episodic positive selection has been observed and analyzed in
detail at individual loci (e.g., [52,53]) but to our knowledge
genome-wide evidence of this phenomenon in mammalian
phylogenies has not previously been reported. Interestingly, our
observations are qualitatively compatible with Gillespie’s theoret-
ical model of an episodic molecular clock [54], although our model
differs from his in detail.
By pooling information across genes and allowing for
uncertainty in selection histories, this method estimates much
larger numbers of genes under positive selection on each branch of
the tree than do the more conservative LRTs (Figure 1). For
example, the expected number of genes under selection on the
branch to the primates is 360.5 (95% CI 338–382), compared with
21 genes identified by the corresponding LRT, and the expected
number under selection on the branch to the rodents is 393.9
(357–426), compared with 56 identified by the corresponding
LRT. In this analysis, the estimated numbers of genes that have
experienced positive selection on the various primate and rodent
lineages are not dramatically different, suggesting that the sharp
differences from the LRTs in large part reflect inequalities in
power. They also suggest that the numbers of genes under
selection in recent human and chimpanzee evolution are not as
different as they appear from LRTs, which will identify only the
most extreme cases [9]. Indeed, the 95% CIs for the human and
chimpanzee estimates heavily overlap.
Examples of Genes with Complex Selection Histories
In addition to being useful in a bulk statistical analysis of all
PSGs, the Bayesian framework can be used to identify the single
most likely selection history for each gene. In some cases, these
histories are consistent with known functional differences between
species, and help to shed light on the evolutionary basis of these
differences. For example, the sweet receptor TAS1R2 has been
shown in knock-out experiments to be responsible for differences
between species in preferences for sweet tastes [55]. (Humans can
taste several natural and artificial sweeteners that mice cannot,
such as monellin, thaumatin, aspartame, and neohesperidin
dihydrochalcone.) This gene is predicted to have experienced
selection on the primate clade and on the branches leading to the
primate and rodent clades (posterior probability [PP] = 0.20),
suggesting that positive selection on TAS1R2 in both primates and
rodents could have contributed to differences in sweet taste
preferences. Another example is the integral membrane glycopro-
tein GYPC, which plays an important role in regulating the
mechanical stability of red blood cells. In humans, GYPC has been
associated with malaria susceptibility, and predicted to have
undergone recent positive selection [56]. However, we find
evidence that GYPC has experienced positive selection on all
branches of the primate clade (PP= 0.66), suggesting longer-term
selective pressure that have also affected nonhuman primates. A
third example is CGA, which encodes the alpha subunit of the four
human glycoprotein hormones (chorionic gonadotropin, luteiniz-
ing hormone, follicle stimulating hormone, and thyroid stimulating
hormone). This gene shows strong evidence of positive selection
specific to the primate clade (PP= 0.82), consistent with the
proposal that relatively recent adaptations in pregnancy and
development have played a critical role in the evolution of the
human endocrine system [57]. Interestingly, the closely related
genes CGB1 and CGB2 (which encode two of the six beta subunits
of chorionic gonadotropin) are thought to have originated by gene
duplication in the common ancestor of humans and great apes
[58], and these events could have contributed to positive selection
on CGA. Finally, the complement components C7 and C8B, which
encode proteases in the membrane attack complex, are predicted
with high probability to be under selection in rodents only (C7:
PP= 0.98 for selection in mouse; C8B: PP= 0.93 for selection in
mouse and rat). Differences in complement proteases are thought
to explain certain differences in the immune responses of humans
and rodents [59].
Gene Expression
We examined the human mRNA expression levels of PSGs
non-PSGs using public data from the Affymetrix Human Exon 1.0
ST Array, which contains probes for nearly all of our genes and
permits accurate estimation of expression levels [60]. Our most
striking finding was that PSGs show reduced expression levels in
all of the 11 available tissues (breast, cerebellum, heart, kidney,
liver, muscle, pancreas, prostate, spleen, testes, and thyroid; see
Methods). In particular, a significantly smaller fraction of PSGs
than of non-PSGs produce a hybridization signal above the
background level for the array (P,461024 in all tissues for PSGs
defined by the all-branch test, one-sided FET). Moreover, among
genes expressed above background, expression levels are signifi-
cantly lower for PSGs than for non-PSGs (P,761025 in all
tissues, one-sided MWU test; Figures 5A–C). PSGs also show
significantly greater tissue bias than non-PSGs, as measured by the
statistic t [61] (Figure 5D) or by an alternative statistic here
denoted c [17] (Methods). The differences in expression level and
tissue bias between the two sets of genes do not appear to be
explained by differences in false negative or false positive rates in
the detection of positive selection, and the differences in expression
level do not appear to be a consequence of the differences in tissue
bias (Text S1). In addition, the observed differences remain if the
genes that belong to strongly enriched GO categories (Table 2) are
excluded, indicating they cannot be attributed to particular classes
of PSGs known to have tissue-specific expression patterns, such as
those involved in immunity or spermatogenesis. That expression
levels are reduced in all tissues further suggests the existence of a
general relationship between expression patterns and the likeli-
hood of positive selection.
Consistent with previous observations (e.g., [62]), we found a
significant negative correlation of v with expression level in all 11
tissues (Spearman’s rank correlation coefficient r ranged from
20.25 to20.43). In addition, we observed a positive correlation of
v with tissue bias, as measured by t (r=0.24) [63,64]. (Similar
correlations were observed when the log likelihood ratio in the test
for positive selection on any branch—which increases with
increasing evidence for selection—was used in place of v.) Unlike
in previous studies, however, we were able to examine these
correlations separately for positively and non-positively selected
genes, using the set of PSGs identified by the all-branches LRT.
Interestingly, the correlations of v with expression level t are
much stronger within the non-PSGs than within the PSGs,
indicating that the observed correlations are primarily driven by
negative rather than positive selection (see also [65]). Thus, while
genes expressed at low levels and/or in a tissue-specific manner
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show an increased tendency to have experienced positive selection,
the strength of positive selection does not appear to be strongly
correlated with their expression patterns (see Discussion).
Of the 15,823 genes that were tested for positive selection and
had detectable expression in at least one tissue, 1,509 showed a
strong preference for one tissue and were designated as tissue
specific (ct.0.25 for some tissue t and ct.0.25 for all t9 ? t; see
Methods). Based on this designation, spleen- and testes-specific
genes were strongly enriched for PSGs: 22 of 174 (12.6%) spleen-
specific genes were PSGs, compared with only 2.2% of other genes
(P=8.7610211, one-sided FET); and 45 of 715 (6.3%) testes-
specific genes were PSGs, compared with 2.1% of other genes
(P=8.2610210). There were also significant, but weaker, enrich-
ments for PSGs among liver-specific (P=9.161023) and breast-
specific (P=1.061022) genes. Not surprisingly, the spleen-specific
PSGs generally appear to be immune-related, and many of the
testes-specific PSGs are involved in spermatogenesis or sperm
adhesion (they include ADAM2 and SPAM1; Table 3). The liver
and breast specific genes are more heterogeneous. In contrast, only
2 of 254 (0.7%) cerebellum-specific genes were PSGs, compared
with 2.3% of other genes (P = 0.066, one-sided FET). Only a few
tissue-specific genes were identified by the clade tests, so it was not
possible to compare the relationships between tissue-specific
expression and positive selection in primates versus rodents.
However, there were significant enrichments for primate PSGs
among spleen-specific genes, and for rodent PSGs among testes-
specific genes.
Despite our large data set, we found no indication of a
correlation between expression in the primate brain and recent
positive selection in protein-coding regions [66] (see [67,68]).
Indeed, we found some evidence to the contrary: PSGs identified
by the primate-clade test show more sharply reduced expression
levels (compared with non-PSGs) in the cerebellum than in any
other tissue; cerebellum-specific genes are depleted, not enriched,
for PSGs; and none of the primate PSGs show tissue-specific
expression in the cerebellum. These findings, of course, do not rule
out positive selection in individual genes of great importance in
brain development, nor do they rule out positive selection on gene
expression.
Average Rates of Protein Evolution and the Impact of
Population Size
While positive selection was our primary focus, our data set also
provides an opportunity to compare the average rates of protein
evolution in various mammalian lineages. We estimated a separate
nonsynonymous-synonymous rate ratio v for each branch of the
six-species phylogeny, pooling data from all ortholog sets
(Figure 1A). Consistent with previous findings [6,8], we observe
that protein-coding genes, on average, have experienced moder-
ately strong purifying selection (v « 1) on all branches of the
phylogeny, but that estimates of v vary considerably within the
mammals. These estimates are largest for the hominids (v<0.25),
smallest for the non-primate mammals (0.12,v#0.14), and
intermediate for non-hominid primates (0.17,v,0.21). It is
thought that increased estimates of v in hominids primarily result
from weakened purifying selection, owing to reduced effective
population sizes [69,5]. The intermediate values for non-hominid
primates may also be influenced by population size.
To examine the relationship between v and population size
further, we made use of a theoretical relationship between v and
the scaled selection coefficient c (see [70,71]), which holds if
nonsynonymous substitutions have equal (and small) selection
coefficients, if synonymous substitutions are neutral, and if
population sizes are sufficiently large (Methods). This relationship
allows ratios of population sizes to be estimated from ratios of v
estimates, under the assumption of constant selection coefficients
across species. Here we further assumed that the ancestral
population sizes of humans and the chimpanzee subspecies Pan
troglodytes versus (to which the sequenced animal belonged) were
roughly the same (Nh=Nc) [5], and estimated the ratio of vm in
macaque to vh in human/chimpanzee from our 10,980 human-
chimpanzee-macaque ortholog trios. Our estimate of vm /
vh=0.732 implies an estimate for the ratio of the macaque to
human ancestral population sizes of Nm / Nh=1.41 [bootstrapping
95% CI (1.15, 1.64)]. In comparison, the ancestral macaque
population size has been estimated at ,73,000 [72] and ancestral
human and chimpanzee population sizes at 40,000–70,000
[73,74], which would imply a ratio of 1.04–1.82, in reasonable
agreement with our estimate. We used the same theoretical
relationship to devise a LRT indicating whether or not each gene
deviated significantly from the assumed model with Nm / Nh=1.41
(Methods). For the vast majority (96%) of the 10,980 genes
examined, no significant deviation was observed, indicating that
the differences in selection pressure in macaque and the hominids
are generally well-explained by differences in population size.
Power Comparison
To compare the power of our LRTs with the power of previous
tests based on hominid or primate genomes, we simulated data sets
under a range of parameter values and measured the fraction of
cases in which positive selection was predicted (Figure 6). These
experiments show that power increases substantially when the set
of species under consideration is expanded from the two hominid
species to the three primates then to all six mammals. With
hominid species only, power is poor even when selection is quite
Figure 5. Distributions of expression levels in PSGs (red) and
non-PSGs (blue) for three tissue types. (A–C) Distributions as
estimated from Affymetrix Human Exon 1.0 ST Array data by the RMA
algorithm [88]. The other eight tissue types showed similar differences
between PSGs and non-PSGs (Figure S7). (D) Distribution of degree of
tissue bias in expression levels for PSGs (red) and non-PSGs (blue), as
measured by the statistic t [61] (Methods). An alternative measure of
tissue bias (c) showed a similar pattern.
doi:10.1371/journal.pgen.1000144.g005
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strong (e.g., ,20% with a constant v=2 and ,40% with v=4),
suggesting that a genome-wide scan will tend to identify only the
most extreme cases of positive selection. If a rigorous correction for
multiple testing is applied, a test based on hominids only has
essentially no power, even for fairly long genes under strong
selection (Figure S3; see also [5]). The situation is considerably
improved by the addition of the macaque genome, but power
remains poor when controlling for multiple testing unless genes are
long and selection is strong. When all six mammals are considered,
however, power increases substantially. With the full data set,
power is reasonably good ($70%) even when genes are short and
selection is moderate in strength; it remains good when multiple
comparisons are considered (Figure S3). The absolute estimates of
power from these experiments depend on the simplifying
assumptions used in the simulations (including the unrealistic
assumption of constant v among lineages and among sites), and
they must be interpreted cautiously. However, estimates of relative
power—which will be less sensitive to these simplifying assump-
tions—indicate a substantial improvement is achieved by the
addition of the three non-primate mammals.
Discussion
Since it first became possible to compare the sequences of
complete mammalian genomes about five years ago, a number of
genome-wide scans for positively selected genes (PSGs) have been
conducted using phylogenetic methods [4,5,6,7,8,9]. These studies
have provided a valuable initial assessement of the genome-wide
landscape of positive selection in mammals, but they have left
many important questions unanswered. The analysis presented
here, by incorporating non-primate mammalian genomes into a
genome-wide scan for positive selection, represents a significant
step forward. The larger, more divergent group of species
improves power significantly, and the use of a nontrivial phylogeny
provides insight into the particular patterns of positive selection
that have helped to shape present-day genes. To our knowledge
this is the largest and most detailed genome-wide analysis of
positive selection to date, not only in mammals but in any group of
organisms (although extensive analyses, similar in some respects,
have been performed recently in Drosophila [75,76]).
One finding of particular interest was that several whole
pathways are especially rich in PSGs. Examples include the
classical and alternative pathways for complement-mediated
immunity and the FAS/p53 apoptotic pathway (Figures S1, S4
and S5). These findings suggest that positive selection may
frequently act directly on whole protein complexes or pathways
(see [77,78]). Alternatively, adaptive changes in one protein may
sometimes have a cascade effect, leading to changes in other genes
that bring a system back into equilibrium. Whether or not all
changes affecting a pathway are driven by positive selection, one
might expect to see similarities in the selection histories of gene
with closely related functions. Indeed, we have found that genes
with similar selection histories on average have substantially
greater similarity in their GO categories than do genes with more
divergent histories (Figure S6). The observations that multiple
interacting genes often show evidence of positive selection and that
positive selection is frequently episodic may well be connected. For
example, in some cases a transient external force could induce a
burst of changes in multiple genes that participate in the same
pathway, either separately or by triggering a cascade of
interdependent events. Further unraveling the (co-)evolutionary
histories of interacting PSGs promises to be a fertile area for future
Table 3. Summary of individual PSGs discussed in this article.
Immunity and Defense
Cytokine/chemokine C-C motif: CCL1 (P= 5.261024), CCL20 (P= 7.661024);
C-X-C and C-X3-C motifs: CXCL5 (P= 8.161024), CX3CL1 (P= 3.061024)
Complement classical pathway: C1S (P= 2.161024), C4BPA (P= 1.461024),
C5AR1 (P= 6.061028), DAF (P= 2.661026)
alternative pathway: CFH (P= 1.461026), CD46 (P= 2.861025),
CFI (P= 1.161024), C7 (P= 3.361026), CD59 (P= 8.261024)
Immunoglobin SIGLEC2/CD22 (P= 1.161029), SIGLEC5 (P= 2.7610220), SIGLEC6 (P= 2.661025), SIGLEC9 (P= 4.361025),
SIGLEC10 (P= 9.561027)
HAVCR1 (P= 6.961029) [interacts with IgA/CD79A (P= 5.461029)]
Sensory preception
Taste receptors sweet: TAS1R2 (P= 1.4261026); bitter: TAS2R1 (P= 1.161027), TAS2R5 (P= 1.161024), TAS2R13
(P= 5.661027), TAS2R14 (P= 2.761024), TAS2R42 (P= 2.261025), TAS2R49 (P= 1.161023), RTP3
(P= 5.261024)
Neurological processes neurotransmitter, neurotensin and neuromedin receptors: SLC6A5 (P= 3.061024), NTSR1 (P= 8.161024),
NMUR (P= 6.161024)
hearing and balance: TMC2 (P= 1.161024)
Metabolism
Diet vitamin B12: TCN1 (P= 2.9610231); starch digestion: MGAM (P= 2.461028); mannose: MAN2B1
(P= 1.061026)
Steriod hormone and drug metabolism detoxification: SULT1C3 (P= 9.7610213), UGT2B7 (P= 6.3610210), CYP2C8 (P= 3.161024)
Fertility
Sperm-egg interaction ADAM2 (P= 2.961026), SPAM1 (P= 2.161024), SPACA (P= 4.161025), WBP2NL (P= 6.461024)
Cancer related genes ADAM2 (P= 2.061026), ADAM15 (P= 5.461024), ADAM29 (P= 3.461024), UNQ5982/ADAM32
(P= 6.261027), CCDC54 (P= 3.361024)
doi:10.1371/journal.pgen.1000144.t003
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work. Care will be required to distinguish between true co-
evolution and correlations that can be explained by dependencies
on expression levels or other covariates of evolutionary rate [79].
Our finding that PSGs are expressed at lower levels and in a
more tissue-specific manner than non-PSGs is consistent with a
well-known negative correlation v with expression level, and a
positive correlation of v with tissue bias (t or c). Various
explanations have been proposed for the observed decrease in v
among genes expressed at high levels and/or expressed broadly
across tissues, including selection for translational efficiency,
selection against misfolding, or increased selection due to
pleiotropy [62,68,65]. In any case, these genes do appear to
experience a reduction in their evolutionary ‘‘flexibility’’ com-
pared with genes expressed at low levels and/or nonuniformly
across tissues. Our observation of decreased rates of positive
selection among these genes—and increased rates among low-
expression/high-tissue-bias genes—is consistent with this charac-
terization. Interestingly, however, we observe that correlations of
Table 4. GO categories showing an excess of small P-values under the primate- and rodent-clade tests.
Primate clade
Category Description No. genes MWU P-value
Biological process
GO:0007606 Sensory perception of chemical stimulus 195 7.7610222
GO:0007608 sensory perception of smell 176 3.0610218
GO:0007600 sensory perception 477 9.2610214
GO:0007186 G-protein coupled receptor protein signaling pathway 684 5.3610213
GO:0007166 cell surface receptor linked signal transduction 1180 1.6610210
GO:0050877 neurological process 711 3.9610207
Molecular function
GO:0004984 olfactory receptor activity 171 6.4610222
GO:0004930 G-protein coupled receptor activity 528 5.1610215
GO:0001584 rhodopsin-like receptor activity 452 3.0610212
GO:0004888 transmembrane receptor activity 827 3.3610211
GO:0004872 receptor activity 1209 3.2610209
GO:0004871 signal transducer activity 1560 1.8610205
GO:0060089 molecular transducer activity 1560 1.8610205
Cellular component
GO:0044425 membrane part 3691 1.5610206
GO:0016021 integral to membrane 3381 1.8610206
GO:0031224 intrinsic to membrane 3398 2.3610206
GO:0016020 membrane 4489 9.6610206
Rodent clade
Category Description No. genes MWU P-value
Biological process
GO:0006952 defense response 248 5.3610210
GO:0009611 response to wounding 226 2.0610209
GO:0006955 immune response 270 3.5610209
GO:0002376 immune system process 378 1.3610208
GO:0006954 inflammatory response 163 1.4610208
GO:0006950 response to stress 532 3.4610207
GO:0009605 response to external stimulus 328 1.3610206
GO:0002541 activation of plasma proteins during acute inflammatory response 18 1.3610206
GO:0006956 complement activation 18 1.3610206
GO:0050896 response to stimulus 1164 2.3610206
GO:0002455 humoral immune response mediated by circulating immunoglobulin 15 7.1610206
GO:0006958 complement activation, classical pathway 14 8.7610206
Cellular component
GO:0005576 extracellular region 601 1.1610205
Shown are numbers of genes classified in each category or a descendant category (out of 14,425 considered in the primate-clade LRT and 10,762 considered in the
rodent-clade LRT) and P -values from the Mann-Whitney U (MWU) test. Bold indicates FWER,0.05.
doi:10.1371/journal.pgen.1000144.t004
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v with expression level and t hold strongly within non-PSGs, but
are much less pronounced within PSGs. Thus, expression levels
and patterns are strongly correlated with both the strength of
negative selection and the likelihood of positive selection, but they
are only weakly correlated with the strength of positive selection. It
appears that genes may be more likely to come under positive
selection if they are in a state of evolutionary flexibility brought on
by reduced or tissue-specific expression, but once positive selection
has taken hold their subsequent evolutionary course is not strongly
dependent on their expression patterns.
As additional mammalian genomes become available, the
statistical power to detect positive selection will improve. However,
most forthcoming genomes are being sequenced at low coverage,
and will inevitably exhibit increased levels of error in base calls,
genome assemblies, ortholog identification (due to short contigs),
and alignment—all of which can lead to spurious signals for
positive selection. (The same errors tend to produce false
negatives, rather than false positives, in the identification of
conserved elements.) Thus, careful data quality controls will be
needed to take advantage of these data. In addition, when
considering the impact of additional sequences on statistical
power, it is useful to distinguish between positive selection that acts
continuously (or in recurrent episodes) over a long evolutionary
period, and positive selection that acts transiently or in a lineage-
specific manner. Deep phylogenetic sequencing should generally
improve detection power for continuous or recurrent positive
selection, but power for transient selection depends strongly on the
sequenced species and the lineages of interest. For example, the
genome sequences of a dozen non-primate mammals will likely
have little effect on the power to detect human-specific selection,
while the gorilla and neanderthal genomes could help consider-
ably. There are fundamental limitations in the detection of weak,
transient, or highly localized positive selection that will not be
overcome by any amount of genome sequencing. Nevertheless, the
availability of several new primate genomes, including those of the
orangutan, marmoset, and gorilla, may significantly improve
power for PSGs in primates.
Our ability to connect positive selection with function remains
rudimentary, but gradual progress is being made. As additional
sequence data becomes available, it will become possible to
associate selection with individual residues of proteins with greater
accuracy. At the same time, more data is becoming available on
the specific functional roles of individual amino acids, for example,
from structural or mutagenesis studies. As a result, it will
increasingly become possible to find direct links between selection
and function. Often these links will initially be tentative, as in our
site-specific analysis of the HAVCR1 gene. Nevertheless, they
provide a valuable starting point for experimental follow-up. At
the same time, more can be done to incorporate non-sequence
data—such as structural and expression data—into computational
methods for detecting positive selection. Thus, improvements in
both computational and experimental methods will be needed to
establish deeper and more informative connections between
evolutionary dynamics and molecular function.
Methods
Ortholog Identification
The latest human (hg18), chimpanzee (panTro2), rhesus
macaque (rheMac2), mouse (mm8), rat (rn4), and dog (canFam2)
genome assemblies were obtained from the University of
California, Santa Cruz (UCSC) Genome Browser. Human-
referenced whole-genome alignments were constructed from
syntenic pairwise alignments with human (the ‘‘syntenic nets’’)
using the UCSC/MULTIZ alignment pipeline [80,81]. Low
quality bases (Phred score ,20) from the chimpanzee, macaque,
rat, and dog genomes were converted to ‘N’s in these alignments.
A starting gene set was composed from of the human RefSeq
[28], UCSC Known Genes [29], and VEGA [30] annotations
(downloaded from UCSC Feb. 19, 2007). Transcripts that lacked
annotated coding regions (CDSs), that had CDSs of ,100 bp, or
that had CDSs whose lengths were not multiples of three were
discarded, leaving 88,879 nonredundant transcripts. These
transcripts were grouped by same-stranded CDS overlap into
21,115 genes (transcript clusters). All transcripts were mapped
from human to each of the other five mammalian species via the
syntenic alignments, then subjected to a series of filters designed to
minimize the impact of annotation errors, sequence quality, and
changes in gene structure on subsequent analyses. Briefly, each
human transcript was required (1) to map to the non-human
genome via a single chain of sequence alignments including$80%
of its CDS; (2) after mapping to a non-human species, to have
#10% of its CDS in sequencing gaps or low quality sequence; (3)
to have no frame-shift indels, unless they were compensated for
within 15 bases; (4) to have no in-frame stop codons and to have all
splice sites conserved. To allow for genes that are mostly conserved
but whose start or stop codons have shifted, incomplete
transcripts—with ,10% of bases removed from the 59 and 39
ends of the CDS—were also considered. The final collection of
ortholog sets was obtained by selecting, for each gene, the
(complete or incomplete) transcript that successfully mapped to the
largest number of non-human species. In the case of a tie, the
transcript with the greatest total CDS length was selected. This
procedure resulted in 17,489 genes with$2 non-human orthologs,
averaging ,5 species per gene (including human; see Table 1).
To establish 1:1 orthology, each human gene and putative non-
human ortholog was examined for evidence of an inparalog (a
Figure 6. Power of the LRT for selection on any branch of the
phylogeny as a function of the nonsynonymous-synonymous
rate ratio v. Power is defined as the fraction of tests resulting in
nominal P,0.05. (The effect of controlling for multiple comparisons is
shown in Figure S3.) When v#1, these fractions are estimates of the
false positive rate. Each data point is based on 1000 data sets simulated
with evolver [84] under the assumption of a constant v among lineages
and among sites (model M0). All other parameters (including the
transition-transversion ratio k, the codon frequencies, and the branch
lengths) were fixed at values estimated from the real data. Results are
shown for short (200-codon) and long (500-codon) genes and three sets
of species: hominids (human and chimpanzee), primates (human,
chimpanzee, and macaque), and all six mammals. Details on the
computation of P-values are given in Text S1. Note the logarithmic scale
on the x-axis.
doi:10.1371/journal.pgen.1000144.g006
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paralog arising from a recent duplication [82]) with respect to the
other species. Specifically, if either gene had a BLASTN match
within the same species (with $80% CDS alignment) that was
more similar than the two orthologs were to each other, then that
gene was considered recently duplicated and was excluded from
the analyses of positive selection. The removal of a duplicated gene
did not require an ortholog set to be discarded entirely, provided a
human gene and $2 nonhuman orthologs still remained. A
collection of genes and gene predictions from the UCSC Genome
Browser were used in the identification of inparalogs. When
comparing rodent vs. non-rodent and rodent vs. rodent distances,
a simple correction for unequal rates of evolution was applied.
Further details are given in Text S1.
Likelihood Ratio Tests
The LRT for selection on any branch of the phylogeny is
essentially Nielsen and Yang’s [31] test of site models 2a versus 1a,
and the lineage- and clade-specific LRTs are essentially instances
of Yang and Nielsen’s [26] test 2 (see also [83,27]). However, to
reduce the number of parameters estimated per gene, the
complete set of 17,489 genes was divided into eight equally sized
classes by G+C content in third codon positions. The branch
lengths and the transition-transversion rate ratio k were estimated
for each class under the null model, and these estimates were
subsequently held fixed, in a G+C dependent way, for the LRTs.
Instead of a complete set of branch lengths, a single scale
parameter m was estimated per gene. Thus, only the parameters m,
v0,1 and p0 for the null model and the additional parameters
v2.1 and p1 for the alternative model, were estimated per gene
(see [31,26]). This parameterization speeds up calculations
substantially compared to estimating k and a set of branch length
per gene, while its sensitivity, specificity and power to detect
positive selection are comparable (Text S1). We developed our
own software for likelihood computation and parameter estima-
tion to support this parameterization.
For the LRT for selection on any branch, P-values were
computed empirically, based on simulation experiments. 10,000
alignments were simulated under the ‘nearly neutral model’
(allowing for a fraction p0 of sites to evolve with v0,1 and a
fraction 12p0 to evolve with v1 = 1) for each G+C class using
evolver [84]. Alignment lengths and values of m, v0 and p0 were
drawn from the empirical distribution defined by the real
alignments (using estimates obtained under the null model), and
the remaining parameters were fixed at global estimates for each
G+C class. Log likelihood ratios (LLRs) were then computed
exactly as for the real data. The nominal P -value for a LLR of r
was defined as the fraction of all simulated alignments with
LLR$r, unless the number of such alignments was ,10, in which
case we assumed 2r*x2df~1 (an adequate approximation for small
P-values, according to the simulation experiments). The method of
Benjamini and Hochberg [85] was used to estimate the
appropriate P-value threshold for a false discovery rate of
,0.05. For the lineage- and clade-specific LRTs, P-values were
computed assuming the null distribution was a 50:50 mixture of a
x2df~1 distribution and a point mass at zero (see [27] and discussion
in Text S1).
Bayesian Inference of Selection Histories
Let X= (X1,…, XN) be the alignment data, with Xi denoting the
alignment for the i th gene (1#i#N; here N=544), and let
Z= (Z1,…, ZN)be the set of selection histories, with Zi denoting the
selection history for the i th gene (1#Zi#M; here M=511). Recall
that a selection history is defined as a pattern of presence or
absence of positive selection on the branches of the unrooted
phylogeny. Let Zib M {0,1} indicate the selective mode (with 1
representing positive selection) for branch b M {1,…,B} (here B=9)
under history Zi. The parameters of the switching model, denoted
h, are defined below. The model assumes independence of genes
and independence of histories, and conditional independence of X
and h given Z. Thus, the complete data likelihood is given by:
P X,Z,hð Þ~P hð Þ PN
i~1
P Xi Zijð ÞP Zi hjð Þ: ð1Þ
The probability of a history, P(Zi|h), is a function of the set of
switches in selective mode required to explain the history
parsimoniously. For each history to be explained parsimoniously,
switches must be allowed to occur early (near the ancestor) or late
(near the descendant) on each internal branch, as well as (early) on
each external branch (Figure 4A; see Text S1 for a justification of
the model). Thus, there are twelve possible switch points, with
three of them adjoining each of the four internal nodes of the tree.
It is convenient to denote these points Pnb : n[N ,b[Bnf g where
N is the set of internal nodes and Bn represents the branches
adjoining node n. Let Vnb M {0,1} and Wnb M {0,1} indicate the
selective states before and after point Pnb, respectively. For a given
history Zi, these variables are uniquely determined by parsimony
according to a simple algorithm (see Text S1). The four possible
values of (Vnb, Wnb) correspond to four possible scenarios at Pnb—
gain of selection (0,1), loss of selection (1,0), absence of gain (0,0),
or absence of loss (1,1). The probabilities of these scenarios (i.e.,
the conditional probability of each Wnb given Vnb) are defined by a
parameter for gains (hnbG) and a parameter for losses (hnbL) at each
point. In addition, the prior probability of selection at the root of
the tree is given by a parameter h0. (For this analysis, the most
recent common ancestor of the primates and rodents is treated as
the root of the tree; see Text S1.) The set of parameters can thus
be described as h~ hnbe : n[N ,b[Bn,e[ G,Lf gf g| h0f g. The
prior probability of a history Zi is simply a product of the prior
and the relevant switching probabilities:
P Zi hjð Þ~hU00 1{h0ð Þ1{U0 P
n[N
P
b[Bn
hWnbnbG 1{hnbGð Þ1{Wnb
h i1{Vnb
| h1{WnbnbL 1{hnbLð ÞWnb
h iVnbð2Þ
where U0 represents the selective state at the root.
The switching model effectively defines a prior distribution over
histories, which tends to favor simpler histories over more complex
ones (typically hnbe,0.5). The prior probability for each element of
h is defined by a (conjugate) Beta distribution with parameters a
and b (here, a=1, b=9). Because these elements are independent
in the prior,
P hð Þ~Beta h0 a,bjð Þ P
n[N
P
b[Bn
P
e[ G,Lf g
Beta hnbe a,bjð Þ: ð3Þ
The term P (Xi | Zi) in equation 1 is simply the likelihood at
gene i of a branch-site codon model that assumes selection history
Zi. A full Bayesian approach would integrate over the parameters
of these codon models, but this would be computationally
prohibitive. Instead, we make the Empirical Bayes simplification
of conditioning the analysis on maximum likelihood estimates of
the parameters of the codon models. The maximized log
likelihoods Lij for all genes i and histories j are precomputed using
existing software (in parallel, on a large computer cluster) and
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stored in an N6M matrix, which is then used in the inference of
selection histories.
The variables Z and h are unobserved, and the goal is to infer
their joint posterior distribution,
P Z,h Xjð Þ~ P X,Z,hð ÞÐ P
Z0 P X,Z
0,hð Þdh : ð4Þ
This inference was accomplished by a Gibbs sampling
algorithm that alternates between sampling each Zi conditional
on Xi and a previously sampled h, and sampling each element of h
conditional on a previously sampled Z. It is straightforward to
derive the required conditional distributions and to sample from
them (Text S1). The Gibbs sampler converges rapidly and mixes
well. Notice that, because the history without selection on any
branch is excluded, all of the histories are described by codon
models with the same number of parameters. Therefore, no
penalty for parameter number is needed when comparing
histories.
After an appropriate burn-in period, each iteration of the Gibbs
sampler produces a sample (Z(t), h(t)) from P(Z, h|X). Estimated
posterior expected values of interest were obtained by averaging
these samples or functions of these samples, and Bayesian 95%
confidence intervals were obtained by taking the 0.025 and 0.975
quantiles of the sampled values. For example, the posterior
expected number of genes under selection on branch k (see
Figure 4) was estimated as 1
T
P
t fk Z
tð Þ
 
, where T is the number
of samples and the function fk(Z) counts the number of genes under
selection on branch k in a set of histories Z.
Analysis of Over-Represented Functional Categories
Each gene was assigned categories from the GO [32] and
PANTHER [86] databases (downloaded on June 26, 2007), based
on the Uniprot identifiers of associated transcripts. At least one
GO category was identified for 14,137 (86%) genes, and at least
one PANTHER category for 13,753 (83%) genes. To account for
the hierarchical nature of these databases, each gene was also
considered to belong to all parent categories of the ones to which it
was directly assigned. For each category C and set of PSGs S, a
262 contingency table was constructed for the numbers of genes
assigned or not assigned to C, and within and outsideS, then a
(one-sided) P-value for independence of rows and columns was
computed by Fisher’s exact test. In addition, the distributions of
LRT P -values among the genes assigned to C and not assigned to
C were compared by a (one-sided) Mann-Whitney U (MWU) test.
(Notice that S is not considered in this case.) Nominal P -values
computed by the FET and MWU tests were corrected for multiple
comparisons using the method of Holm [87].
Gene Expression
The analysis of gene expression was based on the publicly
available ‘‘Tissues+Mixtures’’ sample data set for the Affymetrix
GeneChip Human Exon 1.0 ST Array (http://www.affymetrix.
com/support/technical/sample_data/exon_array_data.affx). The
RMA-based probeset summaries [88] and DABG (detected above
background) -values were used. Each probeset was assigned
genomic coordinates using the ‘‘Affy All Exon’’ track in the UCSC
browser (hg17), then was associated with any human gene from our
set having an exon on the same strand that completely contained the
probeset. Nearly every gene (98%) had at least one probeset.
To calculate a P-value for each gene6tissue, the DABG P-
values of all associated probesets (pooling the three replicates per
probeset6tissue) were combined using Fisher’s method [89]. A
gene was considered to be significantly expressed above back-
ground if it had (nominal) P,0.001. Similarly, an estimated
expression intensity for each gene6tissue was calculated by first
taking the median over the three replicates of each RMA-based
probeset summary, then taking the median of these values over all
probesets associated with the gene. The analysis of expression
intensities was restricted to genes significantly expressed above
background so that genes expressed at or near the background
level did not drive the results.
To measure tissue bias, we used: (1) the statistic t [61], which
represents the average difference in normalized expression
intensity from that of the tissue of maximal expression, and (2) a
statistic, here denoted c, defined as c=maxtct, where ct is the
squared cosine of the angle between the expression vector and the
coordinate axis associated with t (see [17]). In defining genes as
tissue specific for tissue t we required ct.0.25 and ct9,0.125 for all
t9 ? t. Further details are given in Text S1.
Analysis of Average Rates of Protein Evolution and
Population Size
Maximum likelihood estimates of v for each branch were
obtained using the codeml program in the PAML software
package [84], with F364 codon frequencies, estimation of k
(fix_kappa= 0) and a single v across sites per branch (model = 1,
NSsites = 0). The tree topology shown in Figure 1 was assumed.
The alignments for all genes were concatenated for this analysis.
Assuming all non-synonymous mutations at a given gene have
the same selection coefficient and all synonymous mutations are
neutral, population genetic theory says that v should be given by
[70,90]:
v~
4Ns
1{e{4Ns
~
2c
1{e{2c
, ð5Þ
where c=2Ns. Therefore, c can be estimated as f21(v), where
v= f(c) denotes the function above. (Values of c can be obtained
numerically; see Text S1.) Ratios of population sizes can therefore
be estimated from ratios of v estimates: N1
N2
~
c1
c2
~
f{1 v1ð Þ
f{1 v2ð Þ.
The LRT to test whether differences in population size can
explain the differences in v in human and macaque was
constructed as follows. The null model assumes vh=vc and
vm=0.732vh (see Results). The alternative model also assumes
vh=vc but leaves vm as a free parameter to be estimated from the
data. Because the models are nested, a x2df~1 distribution is used
for significance testing. This test was applied separately to each
gene.
Website and Browser Track
A website is available at http://compgen.bscb.cornell.edu/
projects/mammal-psg/ with definitions of the candidate genes
(accession numbers, genomic coordinates, and descriptions),
multiple alignments of orthologous gene sets, GO and PANTHER
category assignments, detailed results of the LRTs and the
Bayesian analysis, and other resources. In addition, the candidate
genes and predicted PSGs are displayed as a track in the UCSC
Genome Browser (http://genome.ucsc.edu; assembly hg18).
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